NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma.
Saved in:
| Title: | NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma. |
|---|---|
| Authors: | Vegliante MC; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Mazzara S; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy., Zaccaria GM; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., De Summa S; Molecular Diagnostics and Pharmacogenetics Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Esposito F; Department of Mathematics, University of Bari Aldo Moro, Bari, Italy.; INDAM-GNCS Research Group, Rome, Italy., Melle F; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy., Motta G; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy., Sapienza MR; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy., Opinto G; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Volpe G; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Bucci A; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Gargano G; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.; INDAM-GNCS Research Group, Rome, Italy., Enjuanes A; Unitat de Genòmica, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona; CIBERONC, Barcelona, Spain., Tabanelli V; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy., Fiori S; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy., Minoia C; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Clemente F; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Negri A; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Gulino A; Cogentech srl Società Benefit, FIRC Institute of Molecular Oncology (IFOM), Milan, Italy., Morello G; Department of Health Sciences, Tumor Immunology Unit, University of Palermo School of Medicine, Palermo, Italy., Scattone A; Pathology Department, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Zito AF; Pathology Department, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Tommasi S; Molecular Diagnostics and Pharmacogenetics Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Agostinelli C; Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy., Vitolo U; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Chiappella A; Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Barbui AM; Department of Oncology and Hematology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy., Derenzini E; Onco-Hematology Division, European Institute of Oncology IRCCS, Milan, Italy.; Department of Health Sciences, University of Milan, Milan, Italy., Zinzani PL; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.; Istituto di Ematologia 'Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Casadei B; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.; Istituto di Ematologia 'Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Rivas-Delgado A; CIBERONC, Barcelona, Spain; Hematology Department, Hospital Clínic, Barcelona; IDIBAPS, Barcelona, Spain., López-Guillermo A; CIBERONC, Barcelona, Spain; Hematology Department, Hospital Clínic, Barcelona; IDIBAPS, Barcelona, Spain., Campo E; CIBERONC, Barcelona, Spain; Haematopathology Unit, Pathology Department, Hospital Clínic, Barcelona; University of Barcelona, Barcelona, Spain., Moschetta A; Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Bari, Italy., Guarini A; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Pileri SA; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy., Ciavarella S; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy. |
| Source: | Hematological oncology [Hematol Oncol] 2022 Dec; Vol. 40 (5), pp. 864-875. Date of Electronic Publication: 2022 Aug 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35850118 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vegliante+MC%22">Vegliante MC</searchLink>; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Mazzara+S%22">Mazzara S</searchLink>; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Zaccaria+GM%22">Zaccaria GM</searchLink>; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22De+Summa+S%22">De Summa S</searchLink>; Molecular Diagnostics and Pharmacogenetics Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Esposito+F%22">Esposito F</searchLink>; Department of Mathematics, University of Bari Aldo Moro, Bari, Italy.; INDAM-GNCS Research Group, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Melle+F%22">Melle F</searchLink>; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Motta+G%22">Motta G</searchLink>; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Sapienza+MR%22">Sapienza MR</searchLink>; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Opinto+G%22">Opinto G</searchLink>; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Volpe+G%22">Volpe G</searchLink>; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Bucci+A%22">Bucci A</searchLink>; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Gargano+G%22">Gargano G</searchLink>; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.; INDAM-GNCS Research Group, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Enjuanes+A%22">Enjuanes A</searchLink>; Unitat de Genòmica, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona; CIBERONC, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Tabanelli+V%22">Tabanelli V</searchLink>; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Fiori+S%22">Fiori S</searchLink>; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Minoia+C%22">Minoia C</searchLink>; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Clemente+F%22">Clemente F</searchLink>; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Negri+A%22">Negri A</searchLink>; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Gulino+A%22">Gulino A</searchLink>; Cogentech srl Società Benefit, FIRC Institute of Molecular Oncology (IFOM), Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Morello+G%22">Morello G</searchLink>; Department of Health Sciences, Tumor Immunology Unit, University of Palermo School of Medicine, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Scattone+A%22">Scattone A</searchLink>; Pathology Department, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Zito+AF%22">Zito AF</searchLink>; Pathology Department, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Tommasi+S%22">Tommasi S</searchLink>; Molecular Diagnostics and Pharmacogenetics Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Agostinelli+C%22">Agostinelli C</searchLink>; Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Vitolo+U%22">Vitolo U</searchLink>; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.<br /><searchLink fieldCode="AU" term="%22Chiappella+A%22">Chiappella A</searchLink>; Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Barbui+AM%22">Barbui AM</searchLink>; Department of Oncology and Hematology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Derenzini+E%22">Derenzini E</searchLink>; Onco-Hematology Division, European Institute of Oncology IRCCS, Milan, Italy.; Department of Health Sciences, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Zinzani+PL%22">Zinzani PL</searchLink>; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.; Istituto di Ematologia 'Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Casadei+B%22">Casadei B</searchLink>; Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.; Istituto di Ematologia 'Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Rivas-Delgado+A%22">Rivas-Delgado A</searchLink>; CIBERONC, Barcelona, Spain; Hematology Department, Hospital Clínic, Barcelona; IDIBAPS, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22López-Guillermo+A%22">López-Guillermo A</searchLink>; CIBERONC, Barcelona, Spain; Hematology Department, Hospital Clínic, Barcelona; IDIBAPS, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Campo+E%22">Campo E</searchLink>; CIBERONC, Barcelona, Spain; Haematopathology Unit, Pathology Department, Hospital Clínic, Barcelona; University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Moschetta+A%22">Moschetta A</searchLink>; Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Guarini+A%22">Guarini A</searchLink>; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Pileri+SA%22">Pileri SA</searchLink>; Division of Hematopathology, European Institute of Oncology, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Ciavarella+S%22">Ciavarella S</searchLink>; Hematology and Cell Therapy Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', Bari, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228307268%22">Hematological oncology</searchLink> [Hematol Oncol] 2022 Dec; Vol. 40 (5), pp. 864-875. <i>Date of Electronic Publication: </i>2022 Aug 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8307268 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1099-1069 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202780232%22">02780232 </searchLink><i>NLM ISO Abbreviation: </i>Hematol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35850118 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/hon.3050 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 864 Titles: – TitleFull: NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vegliante MC – PersonEntity: Name: NameFull: Mazzara S – PersonEntity: Name: NameFull: Zaccaria GM – PersonEntity: Name: NameFull: De Summa S – PersonEntity: Name: NameFull: Esposito F – PersonEntity: Name: NameFull: Melle F – PersonEntity: Name: NameFull: Motta G – PersonEntity: Name: NameFull: Sapienza MR – PersonEntity: Name: NameFull: Opinto G – PersonEntity: Name: NameFull: Volpe G – PersonEntity: Name: NameFull: Bucci A – PersonEntity: Name: NameFull: Gargano G – PersonEntity: Name: NameFull: Enjuanes A – PersonEntity: Name: NameFull: Tabanelli V – PersonEntity: Name: NameFull: Fiori S – PersonEntity: Name: NameFull: Minoia C – PersonEntity: Name: NameFull: Clemente F – PersonEntity: Name: NameFull: Negri A – PersonEntity: Name: NameFull: Gulino A – PersonEntity: Name: NameFull: Morello G – PersonEntity: Name: NameFull: Scattone A – PersonEntity: Name: NameFull: Zito AF – PersonEntity: Name: NameFull: Tommasi S – PersonEntity: Name: NameFull: Agostinelli C – PersonEntity: Name: NameFull: Vitolo U – PersonEntity: Name: NameFull: Chiappella A – PersonEntity: Name: NameFull: Barbui AM – PersonEntity: Name: NameFull: Derenzini E – PersonEntity: Name: NameFull: Zinzani PL – PersonEntity: Name: NameFull: Casadei B – PersonEntity: Name: NameFull: Rivas-Delgado A – PersonEntity: Name: NameFull: López-Guillermo A – PersonEntity: Name: NameFull: Campo E – PersonEntity: Name: NameFull: Moschetta A – PersonEntity: Name: NameFull: Guarini A – PersonEntity: Name: NameFull: Pileri SA – PersonEntity: Name: NameFull: Ciavarella S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2022 Dec Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1099-1069 Numbering: – Type: volume Value: 40 – Type: issue Value: 5 Titles: – TitleFull: Hematological oncology Type: main |
| ResultId | 1 |
